Engineering for Cell Therapy
Kite Pharma’s integrated campus in Maryland expands Kite Pharma’s advanced T-cell manufacturing capacity while prioritizing operational flow and employee well-being.
Cell Therapy Manufacturing Facility
Frederick, MD
Kite Pharma, a leader in cell and gene therapy, develops T-cell treatments that offer transformative potential for cancer patients. To meet growing clinical and commercial demand, the company expanded operations with a new 260,000-square-foot cell therapy manufacturing campus in Frederick, Maryland.
The project required a highly technical facility with robust process controls, staff-centric design, and future scalability. The solution comprises a 200,000-square-foot cGMP manufacturing building paired with a 60,000-square-foot office building. These two functions are seamlessly connected via a central courtyard, which not only supports circulation but also houses amenities such as a putting green, bocce ball court, and outdoor dining areas to enhance employee wellness.
The manufacturing facility includes GMP-compliant clean rooms, QC laboratories, and warehouse space, all designed to maintain flexibility and resilience. A suite separation strategy and independent HVAC systems enable sections of the facility to shut down for cleaning or updates without interrupting other operations. The office building features open workspaces, collaboration and training zones, a fitness center, and a full-service kitchen and dining area.
Together, these integrated environments support a cohesive operation, allowing Kite Pharma to scale its production. The campus also includes room for future expansion that could double manufacturing output, all while maintaining daily operations.
